We are live on ! Find out more
IVM

InterWest Venture Management Portfolio holdings

AUM $20.6M
1-Year Est. Return 48.5%
This Fund
S&P 500
This Quarter Est. Return
+60.54%
1 Year Est. Return
+48.5%
3 Year Est. Return
-57.65%
5 Year Est. Return
-76.52%
10 Year Est. Return
–
AUM
$801M
AUM Growth
+$454M
Cap. Flow
+$232M
Cap. Flow %
28.98%
Top 10 Hldgs %
99.9%
Holding
13
New
1
Increased
–
Reduced
2
Closed
–

Top Buys

Rank Stock Value
1
AI icon
C3.ai
AI
+$233M

Top Sells

Rank Stock Value
1
STIM icon
Neuronetics
STIM
+$273K
2
AGTC
Applied Genetic Technologies Corporation
AGTC
+$252K

Sector Composition

Rank Sector Weight
1 Healthcare 60.55%
2 Technology 30.04%
3 Consumer Discretionary 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PMVP icon
1
PMV Pharmaceuticals
PMVP
$62.9M
$398M 49.71%
6,469,911
– –
AI icon
2
C3.ai
AI
$1.37B
$241M 30.04%
+1,733,467
New +$233M
REAL icon
3
The RealReal
REAL
$1.4B
$75.3M 9.41%
3,854,080
– –
GKOS icon
4
Glaukos
GKOS
$8.92B
$48.6M 6.08%
646,364
– –
STIM icon
5
Neuronetics
STIM
$126M
$11M 1.38%
994,315
-36,374
-4% -$273K
EIGR
6
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$9.4M 1.17%
25,497
– –
KALV
7
DELISTED
KalVista Pharmaceuticals
KALV
$7.38M 0.92%
388,766
– –
AGTC
8
DELISTED
Applied Genetic Technologies Corporation
AGTC
$5.74M 0.72%
1,404,515
-51,389
-4% -$252K
CDTX
9
DELISTED
Cidara Therapeutics
CDTX
$2.71M 0.34%
67,841
– –
VERO
10
DELISTED
Venus Concept
VERO
$1.14M 0.14%
3,992
– –
HIND
11
Vyome Holdings
HIND
$14M
– –
0
– –
XENE icon
12
Xenon Pharmaceuticals
XENE
$6.36B
$128K 0.02%
8,293
– –
DARE icon
13
Dare Bioscience
DARE
$19.8M
$67K 0.01%
4,197
– –

Similar funds

RCP
Rho Capital Partners New York $20.4M AUM
LUGPI
Lightspeed Ultimate General Partner IX Menlo Park, California $20.3M AUM 4.78% 1-Year Est. Return
SIC
Starr International Company Zug, Switzerland $19.9M AUM 39.69% 1-Year Est. Return
DOS
David O. Sacks $19.8M AUM 4.02% 1-Year Est. Return
AA
Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return
CVSCT
C.V. Starr & Co Trust New York $19.4M AUM 28.57% 1-Year Est. Return
VNB
Virginia National Bank Charlottesville, Virginia $21.9M AUM 12.04% 1-Year Est. Return
BEP
Brookside Equity Partners Stamford, Connecticut $22.5M AUM 62.43% 1-Year Est. Return

InterWest Venture Management's Q4 2020 Portfolio in Review

As of Q4 2020, InterWest Venture Management held 13 positions worth $801M, up 131% from $347M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

InterWest Venture Management deployed $232M of net new capital in Q4 2020, opening 1 new position. Its largest new stake was C3.ai: 1,733,467 shares worth $241M.

By sector, the portfolio is most concentrated in Healthcare at 61% of assets, down from 84% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Neuronetics, an estimated $273K trimmed.

  • InterWest Venture Management's largest Q4 2020 buy was C3.ai: 1,733,467 shares worth $241M.
  • InterWest Venture Management's biggest Q4 2020 reduction was Neuronetics, cutting an estimated $273K.
  • InterWest Venture Management's ten largest holdings make up 100% of its $801M portfolio in Q4 2020.
  • InterWest Venture Management opened 1 new position and closed 0 in Q4 2020.
  • InterWest Venture Management's portfolio value rose 131% quarter-over-quarter to $801M.

Based on InterWest Venture Management's 13F filing for Q4 2020, filed 27 Jan 2021.